您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报(医学版) ›› 2016, Vol. 54 ›› Issue (2): 6-10.doi: 10.6040/j.issn.1671-7554.0.2015.411

• • 上一篇    下一篇

MicroRNA-34a在心肌纤维化过程中对SH2B3的表达调控

席福立,张梅   

  1. 山东大学齐鲁医院心内科, 山东 济南 250012
  • 收稿日期:2015-04-23 出版日期:2016-02-10 发布日期:2016-02-10
  • 通讯作者: 张梅. E-mail:zhangm@163.com E-mail:zhangm@163.com

Regulation of microRNA-34a on SH2B3 expression during cardiac fibrosis

XI Fuli, ZHANG Mei   

  1. Department of Cardiology, Qilu Hospital of Shandong University, Jinan 250012, Shandong, China
  • Received:2015-04-23 Online:2016-02-10 Published:2016-02-10

摘要: 目的 探讨SH2B3在心肌纤维化过程中的表达调控机制。 方法 体外培养心肌细胞,在接受不同浓度转化生长因子-β1(10、50、100 ng/mL)和不同缺氧时间(3、6、12、24、48 h)处理后,采用Western blotting检测SH2B3蛋白的表达;采用qRT-PCR法检测SH2B3 mRNA和miR-34a的表达;在心肌细胞中转染miR-34a类似物和miR-34a抑制剂后,采用Western blotting法检测SH2B3蛋白的表达;采用荧光素酶报告基因法检测miR-34a对SH2B3基因3'UTR区活性的影响。 结果 在不同浓度转化生长因子-β1和不同缺氧时间刺激心肌细胞后,SH2B3在mRNA和蛋白的表达水平均降低(P<0.05);miR-34a的表达水平则升高(P<0.05), miR-34a可调控SH2B3的表达(P<0.05); miR-34a通过影响SH2B3 3'UTR活性,调控其表达(P<0.05)。 结论 SH2B3在参与成纤维细胞的纤维化过程中受miR-34a的表达调控。

关键词: 心肌纤维化, 转化生长因子-β1, 缺氧, 微小RNA

Abstract: Objective To explore the pathological mechanism of abnormal SH2B3 expression during cardic fibrosis. Methods After H2C9 cells were treated with transformin growth factor-β1(TGF-β1)at different concentrations(10, 50, and 100 ng/mL)and hypoxia stimulation of various duration(3, 6, 12, 24 and 48 h), the expression of SN2B3 protein was detected with Western blotting, and the SN2B3 mRNA and miR-34a expressions were determined with qRT-PCR. After H2C9 cells were transfected with miR-34a mimic/inhibitor, the SH2B3 expression was examined with Western blotting. The effect of miR-34a on the activity of SH2B3 3'UTR was detected with luciferase activity assay. Results After treatment of TGF-β1 and hypoxia, SH2B3 expression decreased at both mRNA and protein levels(P<0.05), but miR-34a expression increased(P<0.05). The miR-34a could regulate SH2B3 expression by directly binding to 3'UTR(P<0.05). Conclusion SH2B3 participates in the fibrosis process of fibroblasts under the regulation of miR-34a.

Key words: Hypoxia, Cardiac fibrosis, Transformin growth factor-β1, MicroRNA

中图分类号: 

  • R542
[1] Purnomo Y, Piccart Y, Coenen T, et al. Oxidative stress and transforming growthfactor-β1-induced cardiacfibrosis[J]. Cardiovasc Hematol Disord Drug Targets, 2013, 13(2): 165-172.
[2] Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor beta in human disease[J]. N Engl J Med, 2000, 342(18): 1350-1358.
[3] Ahmed Z, Pillay TS. Functional effects of APS and SH2-B on insulin receptor signaling[J]. Biochem Soc Trans, 2001, 29(4): 529-534.
[4] Wang B, Lemay S, Tsai S, et al. SH2 domain-mediated interaction of inhibitory protein tyrosine kinase Csk with protein tyrosine phosphatase HSCF[J]. Mol Cell Biol, 2001, 21(4): 1077-1088.
[5] Devallière J, Charreau B. The adaptor Lnk(SH2B3): an emerging regulator invascular cells and link between immune and inflammatory signaling[J]. Biochem Pharmacol, 2011, 82(10): 1391-1402.
[6] Flister MJ, Hoffman MJ, Lemke A, et al. SH2B3 is genetic determinant of cardiac inflammation and fibrosis[J]. Circ Cardiovasc Genet, 2015, 8(2): 294-304.
[7] Mayer B, Erdmann J, Schunkert H. Genetics and heritability of coronary artery disease and myocardial infarction[J]. Clin Res Cardiol, 2007, 96(1): 1-7.
[8] Dai Y, Khaidakov M, Wang X, et al. MicroRNAs involved in the regulation of postischemic cardiac fibrosis[J]. Hypertension, 2013, 61(4): 751-756.
[9] Huang Y, Qi Y, Du JQ, et al. MicroRNA-34a regulates cardiac fibrosis after myocardial infarction by targeting Smad4[J]. Expert Opin Ther Targets, 2014, 18(12): 1355-1365.
[10] Wei H, Bedja D, Koitabashi N, et al. Endothelial expression of hypoxia-inducible factor1 protects the murine heart and aortafrom pressure overload by suppression of TGF-β signaling[J]. Proc Natl Acad Sci U S A, 2012, 109(14): 841-850.
[11] Zhao X, Wang K, Liao Y, et al. MicroRNA-101a inhibits cardiac fibrosis induced by hypoxia via targeting TGFβRI on cardiac fibroblasts[J]. Cell Physiol Biochem, 2015, 35(1): 213-226.
[1] 贾魁,李治国,程翠婷,李志娟,刘瑞卿. 银杏叶片联合曲美他嗪治疗老年慢性心力衰竭的效果及机制[J]. 山东大学学报 (医学版), 2025, 63(6): 19-26.
[2] 杜艾家,张曼,陈鹤,王丽新,尚应殊. 微小RNA-1270靶向调控血管生成素样蛋白7抑制巨噬细胞炎症和脂质蓄积[J]. 山东大学学报 (医学版), 2025, 63(2): 1-9.
[3] 宋慧梳,孙志坚,张邱婷,弭雪,张妮,王志仑,尹哲,郝学喜,王迎雪. MiR-125a-3p对类风湿关节炎滑膜成纤维细胞增殖的影响[J]. 山东大学学报 (医学版), 2025, 63(12): 74-78.
[4] 曲忠花,迟令懿,马志勇,程振英,王旭平. 缺氧条件下γ-氨基丁酸能系统对视网膜色素上皮的保护作用[J]. 山东大学学报 (医学版), 2025, 63(12): 96-104.
[5] 樊荣,李彬彬,马晓丽,汪运山,郏雁飞. 胃癌中DEC2、HIF-2α的表达及临床意义[J]. 山东大学学报 (医学版), 2023, 61(7): 12-18.
[6] 赵元元,路军涛,吴小华. 人脐带间充质干细胞外泌体miR-100对多囊卵巢综合征患者颗粒细胞炎症的影响[J]. 山东大学学报 (医学版), 2023, 61(5): 51-58.
[7] 华月帆,何珂瑶,张家豪,钱梦凡,刘怡文,孔金玉,杨海军,周福有. 具核梭杆菌诱导缺氧诱导因子及血管生成因子高表达对食管鳞癌患者生存预后的影响[J]. 山东大学学报 (医学版), 2023, 61(11): 59-67.
[8] 徐歌,李青,张灿灿,田永杰. 子宫腺肌病组织及原代细胞中PARP-1、HIF-1α的表达及临床意义[J]. 山东大学学报 (医学版), 2022, 60(4): 55-61.
[9] 高燕,朱庆颖,栾明亚,刘科卫. 托伐普坦联合达格列净对心衰大鼠心肌纤维化的影响[J]. 山东大学学报 (医学版), 2022, 60(12): 13-18.
[10] 张倩,秦明明,何学佳,蔡秋景,张亚民,李庆苏,朱薇薇. 骨化三醇对哮喘中TGF-β1所诱导上皮间充质转化的调控作用[J]. 山东大学学报 (医学版), 2021, 59(7): 10-18.
[11] 张明明,高伟,崔佳,霍丽静,胡晴川,李伟皓,王超. miR-33a在稳定型心绞痛患者血清中的表达及意义[J]. 山东大学学报 (医学版), 2021, 59(6): 64-70.
[12] 杨佳,张曼,陈凯明,曹曦. miR-146a经TLR4/MyD88途径加速巨噬细胞迁移所致动脉硬化的作用机制[J]. 山东大学学报 (医学版), 2021, 59(11): 1-7.
[13] 蔡秋景,张倩,何学佳,孙文丽,郭爱丽,张楠,朱薇薇. 气道平滑肌细胞通过TGF-β1/Smad3信号通路调节IL-33的表达参与哮喘[J]. 山东大学学报 (医学版), 2020, 58(4): 78-83.
[14] 丁华琳,李扬扬,于丰源,战伟伟,于苏国. 达格列净通过Klotho/TGF-β1通路抑制糖尿病肾病大鼠肾纤维化的作用[J]. 山东大学学报 (医学版), 2020, 58(3): 75-80.
[15] 赵位昆,吕祥威,武琦,鲁攀,彭丽,覃秋语. 6-姜酚减轻血管紧张素Ⅱ诱导的大鼠心房纤维化[J]. 山东大学学报 (医学版), 2020, 58(2): 1-6.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!